FDA OKs First Treatment for Rare Types of Vasculitis in Kids FDA OKs First Treatment for Rare Types of Vasculitis in Kids

The FDA has approved rituximab injection for granulomatosis with polyangiitis and microscopic polyangiitis in children aged 2 years or older.FDA Approvals

Source: Medscape Allergy Headlines - September 30, 2019 Category: Allergy & Immunology Tags: Rheumatology News Alert Source Type: news